A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease
Clinical trial NCT07265258 · RECRUITING
Trial details
- NCT number
- NCT07265258
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2028-06-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.